Recent studies demonstrated decreased MEG3 levels in a variety of primary human cancers (Supplementary Table 1) [16, 18, 24, 25, 31–73] and cancer derived cell lines (Table 1) [16, 18, 24, 31, 32, 34–36, 38, 41, 44, 46–54, 56, 57, 59, 60, 62–64, 74–77]. Here, MEG3 is linked to cancer.